Skip to main content

Table 1 Baseline Demographics & Patient-Reported Outcomes

From: Online yoga in myeloproliferative neoplasm patients: results of a randomized pilot trial to inform future research

 

Yoga Group (n = 27)

Control Group (n = 21)

Total (n = 48)

 
 

N (%)

N (%)

N (%)

p

Age, years (M ± SD)

58.3 ± 9.3

55.0 ± 11.4

56.9 ± 10.3

0.28

Body Mass Index (M ± SD)

26.6 ± 5.4

26.2 ± 5.6

26.5 ± 5.4

0.81

Gender

   

0.71

 Male

2 (7.4)

1 (4.8)

3 (6.3)

 

 Female

25 (92.6)

20 (95.2)

45 (93.8)

 

Race

   

0.42

 Caucasian

25 (92.6)

20 (95.2)

45 (93.8)

 

 Other

2 (7.4)

1 (4.8)

3 (6.3)

 

Diagnosis

   

0.53

 Polycythemia Vera

10 (37.0)

5 (23.8)

15 (31.3)

 

 Essential Thrombocythemia

9 (33.3)

10 (47.6)

19 (39.6)

 

 Myelofibrosis

8 (29.6)

6 (28.6)

14 (29.2)

 

Time Since Diagnosis

   

0.44

  < 1 year ago

3 (11.1)

4 (19.0)

7 (14.6)

 

 1–3 years ago

4 (14.8)

4 (19.0)

8 (16.7)

 

  > 3 years ago

20 (74.1)

13 (61.9)

33 (68.8)

 

Presence of Enlarged Spleen

   

0.45

 Yes

8 (29.6)

9 (42.9)

17 (35.4)

 

 No

17 (63.0)

12 (57.1)

29 (60.4)

 

 Missing

2 (7.4)

0 (0.0)

2 (4.2)

 

History of Anemia

   

0.23

 Yes

15 (55.6)

8 (38.1)

23 (47.9)

 

 No

12 (44.4)

13 (61.9)

25 (52.1)

 

Ruxolitinib/Other Janus Kinase-Inhibitor Treatment

  

0.65

 Yes

5 (18.5)

5 (23.8)

10 (20.8)

 

 No

22 (81.5)

16 (76.2)

38 (79.2)

 

Education

   

0.3

  < High School

0 (0.0)

0 (0.0)

0 (0.0)

 

 High school diploma

2 (7.4)

0 (0.0)

2 (4.2)

 

 Some college

1 (3.7)

2 (9.5)

3 (6.3)

 

 Associates/2-year degree

3 (11.1)

0 (0.0

3 (6.3)

 

 Bachelors degree

10 (37.0)

8 (38.1)

18 (37.5)

 

 Graduate school or above

11 (40.7)

11 (52.4)

22 (45.8)

 

Marital status

   

0.28

 Single

2 (7.4)

0 (0.0)

2 (4.2)

 

 Partnered/in a relationship

1 (3.7)

2 (9.5)

3 (6.3)

 

 Married

22 (81.5)

19 (90.5)

41 (85.4)

 

 Separated

2 (7.4)

0 (0.0)

2 (4.2)

 

 Divorced

0 (0.0)

0 (0.0)

0 (0.0)

Â